NCT06730321
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +14 more
- Locations
-
- Shanghai Sixth People's Hospital Shanghai, China
Clinical trial condition
Thyroid cancer, follicular
Explore clinical trials studying Thyroid cancer, follicular. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Thyroid cancer, follicular trial results
NCT04462471
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, BRAF V600E Mutation Positive, +16 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
NCT04544111
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT03690388
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
- Locations
-
- Exelixis Clinical Site #2 Newport Beach, California, United States
- Exelixis Clinical Site #98 Sacramento, California, United States
- Exelixis Clinical Site #69 San Francisco, California, United States
- Exelixis Clinical Site #10 Stanford, California, United States